Abstract
Furin-dependent maturation of the BRI2 protein generates the Bri2-23 fragment that is able to arrest the aggregation of amyloidβ, the peptide implicated in Alzheimer's disease (AD). Bri2-23 contains cysteines at positions 5 and 22, which are likely to bind to metal ions such as Cu(i). Metal ions may play a role in the etiology of neurodegenerative disorders such as AD, and in this work we explore the metal ion induced folding and aggregation of Bri2-23 using Hg(ii) and Ag(i) as spectroscopic probes with structural and ligand preferences similar to those of Cu(i), while not displaying redox activity under the experimental conditions. In general, interaction of Bri2-23 with soft metal ions changes the structural properties and solution behavior of the peptide that tune to increasing metal to peptide stoichiometry. Potentiometric, (199m)Hg PAC and ESI-MS data indicate that addition of up to 0.5 equivalents of Hg(ii) to Bri2-23 yields a two-coordinated HgS2 structure at the metal site. While the free peptide is inherently unstructured, the presence of Ag(i) and Hg(ii) gives rise to β-sheet formation. NMR spectroscopy supports the formation of β-sheet structure in the presence of 0.5 equivalents of Hg(ii), and displays an interesting and marked change in the TOCSY spectra when increasing the Hg(ii) to peptide stoichiometry from 0.5 to 0.7 equivalents, indicating the equilibrium between two structural analogues of the complex. Addition of more than 0.7 equivalents of Hg(ii) gives rise to line broadening, presumably reflecting aggregation. This is further supported by ThT fluorescence studies showing that the Bri2-23 peptide does not aggregate over 24 hours, while addition of over 0.7 equivalents of Ag(i) or Hg(ii) leads to increase of fluorescence, indicating that these metal ions induce aggregation. Thus, a model integrating all data into a coherent picture is that the metal ion binding to the two thiolates gives rise to folding of the peptide into a structure that is prone to aggregation, forming aggregates with a considerable amount of β-sheets. Molecular dynamics simulations initiated with structures that agree with NMR data additionally support this model.
Highlights
To WT BRI2, ABriPP and ADanPP proteins undergo proteolytic cleavage at the C-terminal region generating ABri and ADan peptides (Fig. 1).[2,3]. These peptides constitute the hallmarks of the Familiar British Dementia (FBD) and Familiar Danish Dementia (FDD) disorders, that share many mechanistic and pathological similarities with Alzheimer’s disease (AD).[1]. This process is initialized by the activation of the convertase in the trans region of the Golgi apparatus and continues once the secretory vesicle merges with the cellular membrane
ThT fluorescence spectroscopy assay The thioflavin-T (ThT) fluorimetric assay is widely used to underline the presence of a stable b sheet secondary structure for peptides or proteins.[52,53]
The structural propensity of the Bri2-23–Hg(II) complex was investigated by Molecular Dynamics Simulations (MD) performed on seven random structures selected from the thirty ones generated from DYANA calculation (Fig. 7S, Electronic supplementary information (ESI)†)
Summary
Furin-dependent maturation of the BRI2 protein generates the Bri[2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23] fragment that is able to arrest the aggregation of amyloidb, the peptide implicated in Alzheimer’s disease (AD). The difference spectra (Fig. 4D) obtained by subtracting the CD spectra of the apo peptide from the metal complexes have the typical shape of those of b sheet proteins, supporting the ThT results indicating that Bri[2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23] forms a b sheet structure in the presence of both Hg(II) and Ag(I) ions.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have